Effects of simvastatin 20 mg/d on serum lipid profiles in Japanese hyperlipidemic patients: A prospective, open-label pilot study

BACKGROUND: Hyperlipidemia is a major risk factor for ischemic heart disease. Hydroxymethylglutaryl coenzyme A reductase inhibitors (“statins”) (eg, simvastatin) are considered first-line cholesterol-lowering therapy because they are effective and well tolerated, even at high doses. Based on a liter...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yoshida, Hiroshi, Yanai, Hidekatsu, Shoda, Toru, Furutani, Nobuyuki, Sato, Noriko, Tada, Norio
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2005
Materias:
Trials in Special Populations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3997116/
https://ncbi.nlm.nih.gov/pubmed/24764596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2005.12.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares